NovAccess Global (OTCMKTS:XSNX) Posts Earnings Results

Posted by on Jan 15th, 2026

NovAccess Global (OTCMKTS:XSNX – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, Zacks reports.

NovAccess Global Price Performance

NovAccess Global has a 12 month low of $0.00 and a 12 month high of $0.05.

About NovAccess Global

(Get Free Report)

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Read More

Earnings History for NovAccess Global (OTCMKTS:XSNX)

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.